1. Home
  2. BYON vs GOSS Comparison

BYON vs GOSS Comparison

Compare BYON & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYON
  • GOSS
  • Stock Information
  • Founded
  • BYON 1997
  • GOSS 2015
  • Country
  • BYON United States
  • GOSS United States
  • Employees
  • BYON N/A
  • GOSS N/A
  • Industry
  • BYON Catalog/Specialty Distribution
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BYON Consumer Discretionary
  • GOSS Health Care
  • Exchange
  • BYON Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • BYON 262.5M
  • GOSS 237.9M
  • IPO Year
  • BYON N/A
  • GOSS 2019
  • Fundamental
  • Price
  • BYON $5.95
  • GOSS $0.92
  • Analyst Decision
  • BYON Buy
  • GOSS Strong Buy
  • Analyst Count
  • BYON 10
  • GOSS 5
  • Target Price
  • BYON $17.00
  • GOSS $9.20
  • AVG Volume (30 Days)
  • BYON 3.0M
  • GOSS 2.0M
  • Earning Date
  • BYON 02-18-2025
  • GOSS 03-04-2025
  • Dividend Yield
  • BYON N/A
  • GOSS N/A
  • EPS Growth
  • BYON N/A
  • GOSS N/A
  • EPS
  • BYON N/A
  • GOSS N/A
  • Revenue
  • BYON $1,476,271,000.00
  • GOSS $105,322,000.00
  • Revenue This Year
  • BYON N/A
  • GOSS N/A
  • Revenue Next Year
  • BYON $4.55
  • GOSS N/A
  • P/E Ratio
  • BYON N/A
  • GOSS N/A
  • Revenue Growth
  • BYON N/A
  • GOSS N/A
  • 52 Week Low
  • BYON $4.45
  • GOSS $0.50
  • 52 Week High
  • BYON $37.10
  • GOSS $1.60
  • Technical
  • Relative Strength Index (RSI)
  • BYON 54.30
  • GOSS 51.97
  • Support Level
  • BYON $5.63
  • GOSS $0.81
  • Resistance Level
  • BYON $6.72
  • GOSS $1.18
  • Average True Range (ATR)
  • BYON 0.48
  • GOSS 0.08
  • MACD
  • BYON 0.18
  • GOSS 0.01
  • Stochastic Oscillator
  • BYON 66.00
  • GOSS 34.08

About BYON Beyond Inc.

Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad range of products, including furniture, décor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items. The home and garden product line accounts for a material part of its total revenue. The company operates through a direct business that makes sales from the company's own inventory, and a partner business that sells merchandise from manufacturers, distributors, and other suppliers through the company's websites. The company generates the majority of its total revenue from partner business in terms of business format, and from the U.S. in terms of market.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: